Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5

The epithelial-mesenchymal transition (EMT) is one mechanism by which cells with mesenchymal features can be generated and is a fundamental event in morphogenesis. Recently, invasion and metastasis of cancer cells from the primary tumor are now thought to be initiated by the developmental process termed the EMT, whereby epithelial cells lose cell polarity and cell-cell interactions, and gain mesenchymal phenotypes with increased migratory and invasive properties. The EMT is believed to be an important step in metastasis and is implicated in cancer progression, although the influence of the EMT in clinical specimens has been debated. This review presents the recent results of two cell surface proteins, the functions and underlying mechanisms of which have recently begun to be demonstrated, as novel regulators of the molecular networks that induce the EMT and cancer progression.

• Publication year

  2014

• Venue

  Genomics & Informatics

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.5808/GI.2014.12.1.12PMID 24748857PMCID 3990761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis

  2014cited by this paper
• TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion.

  2014cited by this paper
• Regulation of microRNAs in cancer metastasis.

  2014cited by this paper
• Prognostic value of interleukin-8 and MMP-9 in nasopharyngeal carcinoma

  2014cited by this paper
• Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies

  2014cited by this paper
• Discovery of novel 2-hydroxydiarylamide derivatives as TMPRSS4 inhibitors.

  2013cited by this paper
• The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation.

  2013cited by this paper
• A High Level of TM4SF5 Is Associated with Human Esophageal Cancer Progression and Poor Patient Survival

  2013cited by this paper
• Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

  2013cited by this paper
• Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance.

  2013cited by this paper
• TMPRSS4 as a Poor Prognostic Factor for Triple-Negative Breast Cancer

  2013cited by this paper
• The Expression of TMPRSS4 and Erk1 Correlates with Metastasis and Poor Prognosis in Chinese Patients with Gastric Cancer

  2013cited by this paper
• Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl4‐treated mice

  2012cited by this paper
• Targeting tetraspanins in cancer

  2012cited by this paper
• EMT and dissemination precede pancreatic tumor formation.

  2012cited by this paper
• EMT as the ultimate survival mechanism of cancer cells.

  2012cited by this paper
• Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia

  2012cited by this paper
• Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition.

  2012cited by this paper
• Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial-mesenchymal transition.

  2012cited by this paper
• JNK signaling activity regulates cell-cell adhesions via TM4SF5-mediated p27(Kip1) phosphorylation.

  2012cited by this paper
• Tetraspan TM4SF5-dependent direct activation of FAK and metastatic potential of hepatocarcinoma cells

  2012cited by this paper
• Plasticity of disseminating cancer cells in patients with epithelial malignancies

  2012cited by this paper
• ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.

  2012cited by this paper
• TMPRSS4 is a type II transmembrane serine protease involved in cancer and viral infections

  2012cited by this paper
• A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice

  2011cited by this paper
• Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology

  2011cited by this paper
• Proteasome inhibition causes epithelial–mesenchymal transition upon TM4SF5 expression

  2011influential reference
• Angiogenesis , Metastasis , and the Cellular Microenvironment Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers

  2011cited by this paper
• Modulation of signaling between TM4SF5 and integrins in tumor microenvironment.

  2011influential reference
• The complexity of tetraspanins.

  2011cited by this paper
• Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial–mesenchymal transition

  2011cited by this paper
• Quantifying colocalization by correlation: The Pearson correlation coefficient is superior to the Mander's overlap coefficient

  2010cited by this paper
• The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?

  2010cited by this paper
• TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways.

  2010influential reference
• Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion: Role of EMT promoting Smad complexes

  2010cited by this paper
• TM4SF5 accelerates G1/S phase progression via cytosolic p27Kip1 expression and RhoA activity.

  2010cited by this paper
• Epithelial–Mesenchymal Transition: From Molecular Mechanisms, Redox Regulation to Implications in Human Health and Disease

  2010cited by this paper
• Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis

  2010cited by this paper
• Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells.

  2010cited by this paper
• Cooperation between integrin alpha5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity.

  2009influential reference
• Blockade of four‐transmembrane L6 family member 5 (TM4SF5)‐mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative

  2009cited by this paper
• The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma.

  2009cited by this paper
• Type II Transmembrane Serine Proteases*

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009influential reference
• EMT: when epithelial cells decide to become mesenchymal-like cells.

  2009cited by this paper
• Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes.

  2009cited by this paper
• The extracellular loop 2 of TM4SF5 inhibits integrin alpha2 on hepatocytes under collagen type I environment.

  2009cited by this paper
• Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.

  2009cited by this paper
• Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma.

  2008influential reference
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• CDK inhibitors: cell cycle regulators and beyond.

  2008cited by this paper
• Type II transmembrane serine proteases in development and disease.

  2008influential reference
• The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

  2008cited by this paper
• Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

  2008influential reference
• TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial–mesenchymal transition

  2008cited by this paper
• Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer

  2008cited by this paper
• Tetraspanins as Regulators of Protein Trafficking

  2007cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cells

  2007cited by this paper
• Focal adhesion and actin organization by a cross-talk of TM4SF5 with integrin alpha2 are regulated by serum treatment.

  2006cited by this paper
• Activation of epithelial sodium channels by mouse channel activating proteases (mCAP) expressed in Xenopus oocytes requires catalytic activity of mCAP3 and mCAP2 but not mCAP1.

  2006cited by this paper
• A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer.

  2006cited by this paper
• Matrix metalloproteinases and tumor metastasis

  2006cited by this paper
• Complex networks orchestrate epithelial–mesenchymal transitions

  2006influential reference
• Tumor cell invasiveness correlates with changes in integrin expression and localization

  2005cited by this paper
• Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability

  2005cited by this paper
• Extent of disease and practice patterns for medullary thyroid cancer.

  2005cited by this paper
• Cell adhesion and signalling by cadherins and Ig-CAMs in cancer

  2004cited by this paper
• Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance.

  2004cited by this paper
• p27Kip1 modulates cell migration through the regulation of RhoA activation.

  2004cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004influential reference
• Functional domains in tetraspanin proteins.

  2003cited by this paper
• Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain.

  2003cited by this paper
• Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer

  2003cited by this paper
• Phosphorylation of p27Kip1 at Threonine 198 by p90 Ribosomal Protein S6 Kinases Promotes Its Binding to 14-3-3 and Cytoplasmic Localization*

  2003influential reference
• Type II transmembrane serine proteases.

  2003cited by this paper
• Type II transmembrane serine proteases

  2003cited by this paper
• Synergistic Activation of ENaC by Three Membrane-bound Channel-activating Serine Proteases (mCAP1, mCAP2, and mCAP3) and Serum- and Glucocorticoid-regulated Kinase (Sgk1) in Xenopus Oocytes

  2002cited by this paper
• Identification of genes associated with the corticotroph phenotype in bronchial carcinoid tumors.

  2002cited by this paper
• PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest

  2002cited by this paper
• Complexes of tetraspanins with integrins: more than meets the eye.

  2001cited by this paper
• Amount of expression of the tumor-associated antigen L6 gene and transmembrane 4 superfamily member 5 gene in gastric cancers and gastric mucosa

  2001cited by this paper
• Proteases in invasion: matrix metalloproteinases.

  2001cited by this paper
• Type II Transmembrane Serine Proteases

  2001cited by this paper
• A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer.

  2000cited by this paper
• Type II Transmembrane Serine Proteases INSIGHTS INTO AN EMERGING CLASS OF CELL SURFACE PROTEOLYTIC ENZYMES*

  2000cited by this paper
• The L6 membrane proteins—A new four‐transmembrane superfamily

  2000cited by this paper
• Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.

  1999cited by this paper
• Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells.

  1999cited by this paper
• Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer.

  1998cited by this paper
• Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis

  1997cited by this paper
• The urokinase‐type plasminogen activator system in cancer metastasis: A review

  1997cited by this paper
• Proteases as prognostic markers in cancer.

  1996cited by this paper
• Enterokinase, the initiator of intestinal digestion, is a mosaic protease composed of a distinctive assortment of domains.

  1994cited by this paper
• Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

  1991cited by this paper

• Decoding the mechanical language of the tumor microenvironment: From physical forces to malignant behaviors.

  2026cites this paper
• Overexpression of heat shock protein 47 is associated with increased proliferation and metastasis in gastric cancer

  2024cites this paper
• TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer

  2023cites this paper
• Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance

  2023influential citation
• Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models

  2022cites this paper
• TMPRSS4 promotes cancer stem–like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1

  2021cites this paper
• Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial–mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKT

  2021cites this paper
• An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer

  2020cites this paper
• Fluidity of Poly (ε-Caprolactone)-Based Material Induces Epithelial-to-Mesenchymal Transition

  2020cites this paper
• Activation of Viruses by Host Proteases

  2019cites this paper
• Role of TMPRSS4 Modulation in Breast Cancer Cell Proliferation

  2019cites this paper
• Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4

  2019cites this paper
• A proteomics outlook towards the elucidation of epithelial-mesenchymal transition molecular events.

  2019cites this paper
• Membrane-Anchored Serine Proteases: Host Cell Factors in Proteolytic Activation of Viral Glycoproteins

  2018cites this paper
• Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine–Paracrine Loop

  2018cites this paper
• Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury

  2018cites this paper
• TMPRSS4 Upregulates TWIST1 Expression through STAT3 Activation to Induce Prostate Cancer Cell Migration

  2018cites this paper
• A Cell-Surface Membrane Protein Signature for Glioblastoma.

  2017cites this paper
• Development of biological tools to assess the role of TMPRSS4 and identification of novel tumor types with high expression of this prometastatic protein.

  2017cites this paper
• TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.

  2016cites this paper
• EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression

  2016cites this paper
• TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1

  2016cites this paper
• TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis

  2016cites this paper
• Identification of potential transmembrane protease serine 4 inhibitors as anti-cancer agents by integrated computational approach.

  2016cites this paper
• TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection

  2015cites this paper
• Epithelial Sodium Channel-Mediated Sodium Transport Is Not Dependent on the Membrane-Bound Serine Protease CAP2/Tmprss4

  2015cites this paper
• Cancer Invasion: Patterns and Mechanisms

  2015cites this paper
• Clinical significance of TMPRSS 4 in prostate cancer

  2014cites this paper
• Clinical significance of TMPRSS4 in prostate cancer.

  2014cites this paper